Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
1 active warrant series covering 2,380,951 shares (~1.9% potential dilution); nearest expiry 2028-10-29.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.14 | Oct 29, 2028 749d | 2.4M | ITM | 1.9% | C$333K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
7 option grants covering 8,340,133 shares (~6.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.34 | Jan 7, 2027 88d | 25K | OTM | 0.0% | C$9K | Auto |
| option | $0.06 | Aug 17, 2027 310d | 1.7M | ITM | 1.3% | C$100K | Auto |
| option | $0.25 | Sep 19, 2028 709d | 90K | OTM | 0.1% | C$22K | Auto |
| option | $0.06 | Jun 30, 2029* 993d | 3.5M | ITM | 2.8% | C$210K | Auto |
| option | $0.14 | Jul 7, 2029 1000d | 1.1M | ITM | 0.9% | C$154K | Auto |
| option | $0.08 | Jan 23, 2030 1200d | 118K | ITM | 0.1% | C$9K | Auto |
| option | $0.08 | Jan 30, 2030 1207d | 1.8M | ITM | 1.5% | C$147K | Auto |
124,445,920 shares outstanding, plus 2,380,951 from warrants and 8,340,133 from options, and 1,745,646 from restricted share units — a fully diluted 136,912,650 shares, or ~10% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.